Vertex Pharmaceuticals Incorporated
VRTX
$424.99
-$4.61-1.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.03% | -45.48% | -45.30% | -48.42% | -2.33% |
| Total Receivables | 0.66% | 2.94% | 13.77% | 6.42% | 15.85% |
| Inventory | 67.22% | 63.16% | 56.79% | 51.55% | 51.95% |
| Prepaid Expenses | 22.86% | -14.58% | -11.55% | 12.98% | 6.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 62.33% | 139.84% | -76.24% | 415.38% | 49.60% |
| Total Current Assets | -24.68% | -32.15% | -33.29% | -35.55% | 2.49% |
|
|
|||||
| Total Current Assets | -24.68% | -32.15% | -33.29% | -35.55% | 2.49% |
| Net Property, Plant & Equipment | 77.32% | 77.89% | 75.25% | 22.40% | 2.60% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -47.16% | -1.67% | 37.77% | 38.75% | 38.32% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.14% | 20.62% | 53.16% | 60.24% | 63.69% |
| Total Assets | -4.34% | -0.87% | 2.37% | -1.07% | 26.05% |
|
|
|||||
| Total Accounts Payable | 26.64% | 13.18% | 5.29% | -9.67% | 8.73% |
| Total Accrued Expenses | 5.58% | 2.81% | 10.75% | 13.16% | 20.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 10.27% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -40.43% | -20.48% | -9.42% | -28.57% | 72.04% |
| Total Other Current Liabilities | -40.43% | -20.48% | -9.42% | -28.57% | 72.04% |
| Total Current Liabilities | -0.33% | 0.48% | 10.38% | 5.82% | 25.43% |
|
|
|||||
| Total Current Liabilities | -0.33% | 0.48% | 10.38% | 5.82% | 25.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 128.63% | 128.67% | 128.67% | 21.60% | -8.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.52% | 2.75% | 7.36% | 15.47% | 17.49% |
| Total Liabilities | 18.87% | 18.91% | 26.78% | 9.81% | 18.25% |
|
|
|||||
| Common Stock & APIC | -15.26% | -10.43% | -5.91% | -3.63% | 0.89% |
| Retained Earnings | -8.80% | -5.28% | -5.23% | -6.02% | 55.65% |
| Treasury Stock & Other | 293.64% | 993.71% | 1,060.00% | 156.53% | 232.06% |
| Total Common Equity | -11.05% | -6.66% | -5.34% | -4.50% | 28.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.05% | -6.66% | -5.34% | -4.50% | 28.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.05% | -6.66% | -5.34% | -4.50% | 28.51% |
|
|
|||||